دورية أكاديمية

UK's Association of British Clinical Diabetologist's Diabetes Technology Network (ABCD‐DTN): Best practice guide for hybrid closed‐loop therapy.

التفاصيل البيبلوغرافية
العنوان: UK's Association of British Clinical Diabetologist's Diabetes Technology Network (ABCD‐DTN): Best practice guide for hybrid closed‐loop therapy.
المؤلفون: Griffin, Tomás P., Gallen, Geraldine, Hartnell, Sara, Crabtree, Thomas, Holloway, Melissa, Gibb, Fraser W., Lumb, Alistair, Wilmot, Emma G., Choudhary, Pratik, Hussain, Sufyan
المصدر: Diabetic Medicine; Jul2023, Vol. 40 Issue 7, p1-21, 21p
مصطلحات موضوعية: TREATMENT of diabetes, THERAPEUTICS, OCCUPATIONAL roles, REFERENCE values, TEAMS in the workplace, BLOOD sugar monitoring, MEDICAL protocols, LABOR supply, INSULIN pumps, AUTOMATION, HYPOGLYCEMIA, HEALTH care teams, TECHNOLOGY, PHYSICIANS, MEDICAL societies
مصطلحات جغرافية: UNITED Kingdom
مستخلص: This best practice guide is written with the aim of providing an overview of current hybrid closed‐loop (HCL) systems in use within the United Kingdom's (UK) National Health Service (NHS) and to provide education and advice for their management on both an individual and clinical service level. The environment of diabetes technology, and particularly HCL systems, is rapidly evolving. The past decade has seen unprecedented advances in the development of HCL systems. These systems improve glycaemic outcomes and reduce the burden of treatment for people with type 1 diabetes (pwT1D). It is anticipated that access to these systems will increase in England as a result of updates in National Institute of Health and Care Excellence (NICE) guidance providing broader support for the use of real‐time continuous glucose monitoring (CGM) for pwT1D. NICE is currently undertaking multiple‐technology appraisal into HCL systems. Based on experience from centres involved in supporting advanced technologies as well as from the recent NHS England HCL pilot, this guide is intended to provide healthcare professionals with UK expert consensus on the best practice for initiation, optimisation and ongoing management of HCL therapy. [ABSTRACT FROM AUTHOR]
Copyright of Diabetic Medicine is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:07423071
DOI:10.1111/dme.15078